These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18367018)

  • 1. Cardiovascular risk in patients with chronic kidney disease: not high enough to enter the major league?
    Zoccali C
    Curr Hypertens Rep; 2008 Feb; 10(1):1-2. PubMed ID: 18367018
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of chronic kidney disease.
    Frankel A; Brown E; Wingfield D
    BMJ; 2005 May; 330(7499):1039-40. PubMed ID: 15879372
    [No Abstract]   [Full Text] [Related]  

  • 3. Automatic reporting of the estimated glomerular filtration rate (eGFR).
    DuBose TD
    N C Med J; 2008; 69(3):215-8. PubMed ID: 18751355
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular risk reduction and preservation of renal function in the early nephropathy patient.
    McCullough PA
    Adv Chronic Kidney Dis; 2004 Apr; 11(2):184-91. PubMed ID: 15216489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glomerular filtration rate is an indicator of endothelial function at early stages of chronic kidney disease].
    Smirnov AV; Petrishchev NN; Panina IIu; Rumiantsev ASh; Degtereva OA; Tugusheva FA; Menshutina MA
    Ter Arkh; 2007; 79(6):25-30. PubMed ID: 17684962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is early chronic kidney disease an important risk factor for cardiovascular disease? A background paper prepared for the UK Consensus Conference on early chronic kidney disease.
    Daly C
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 9():ix19-25. PubMed ID: 17998227
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality.
    Sharma S; Sarnak MJ
    Nat Rev Nephrol; 2017 Aug; 13(8):447-448. PubMed ID: 28626221
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical commentary: how to choose blood pressure goals and treatment: influence of estimated glomerular filtration rate and albuminuria.
    Weir MR
    Trans Am Clin Climatol Assoc; 2008; 119():53-61; discussion 61-3. PubMed ID: 18596856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy.
    Middleton JP; Pun PH
    Kidney Int; 2010 May; 77(9):753-5. PubMed ID: 20393488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strengths and weaknesses of renal markers as risk factors and surrogate markers.
    Johnson KR
    Kidney Int; 2011 Jun; 79(12):1272-4. PubMed ID: 21625257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular peculiarities in patients with chronic kidney disease.
    Musiał K; Zwolińska D
    Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):3. PubMed ID: 23046247
    [No Abstract]   [Full Text] [Related]  

  • 12. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiorenal intersection: crossroads to the future.
    McCullough PA
    Arq Bras Cardiol; 2007 Jan; 88(1):117-26. PubMed ID: 17364130
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiorenal risk factors.
    Wall BM
    Am J Med Sci; 2010 Jul; 340(1):25-9. PubMed ID: 20610968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JUPITER "moderate CKD" subgroup is not truly "moderate" chronic kidney disease.
    Roberts MA; Hare DL
    J Am Coll Cardiol; 2010 Aug; 56(6):528; author reply 530. PubMed ID: 20670769
    [No Abstract]   [Full Text] [Related]  

  • 16. Does an Acid-Milieu in Chronic Kidney Disease Contribute to Its Increased Cardiovascular Mortality?
    Wesson DE
    Am J Nephrol; 2016; 43(6):408-10. PubMed ID: 27229524
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes of cardiovascular system in patients with chronic renal failure].
    Shugushev KhKh; Khamizova MM; Vasilenko VM; Shugushev ZKh
    Kardiologiia; 2003; 43(3):75-9. PubMed ID: 12913985
    [No Abstract]   [Full Text] [Related]  

  • 18. The case for using albuminuria in staging chronic kidney disease.
    Gansevoort RT; de Jong PE
    J Am Soc Nephrol; 2009 Mar; 20(3):465-8. PubMed ID: 19255126
    [No Abstract]   [Full Text] [Related]  

  • 19. MMP-7 as a potential marker of cardiovascular complications in patients with chronic kidney disease (CKD).
    Musiał K; Zwolińska D
    Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):73-4. PubMed ID: 22540933
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic renal failure: a cardiovascular risk factor.
    Fort J
    Kidney Int Suppl; 2005 Dec; (99):S25-9. PubMed ID: 16336573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.